Date  |
|
| Jun 22, 2020 |
Celcuity Presents Data at AACR Annual Meeting for CELsignia Pathway Activity Test for Ovarian Cancer |
| Jul 1, 2020 |
Celcuity Hosting Call on CELsignia Pathway Activity Test for Ovarian Cancer |
| Jul 24, 2020 |
Celcuity Inc. Schedules Release of Second Quarter 2020 Financial Results and Conference Call |
| Aug 10, 2020 |
Celcuity Reports Second Quarter 2020 Financial Results and Recent Business Highlights |
| Aug 27, 2020 |
Celcuity to Present at the LD Micro 500 Investor Conference |
| Oct 26, 2020 |
Celcuity Inc. Schedules Release of Third Quarter 2020 Financial Results and Conference Call |
| Nov 9, 2020 |
Celcuity Reports Third Quarter 2020 Financial Results and Recent Business Highlights |
| Dec 23, 2020 |
Celcuity Announces Clinical Trial Collaboration with Massachusetts General Hospital and Puma Biotechnology |
| Jan 19, 2021 |
Celcuity to Present at the B. Riley Oncology Investor Conference |
| Jan 27, 2021 |
Celcuity Announces Breast Cancer Clinical Trial Collaboration with Sarah Cannon and Pfizer to Study New Drug Regimen |
| Feb 1, 2021 |
Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2020 Financial Results and Conference Call |
| Feb 16, 2021 |
Celcuity Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights |
| Feb 22, 2021 |
Celcuity Announces Proposed Public Offering of Common Stock |
| Feb 24, 2021 |
Celcuity Prices Upsized Public Offering of Common Stock |
| Mar 1, 2021 |
Celcuity Announces Closing of Common Stock Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares of Common Stock |